Assignee
THERAVECTYS
FR6 patents
Top patents by PatentIndex Score
US10752668B2Aug 25, 2020
Lentiviral vectors for regulated expression of a chimeric antigen receptor molecule
THERAVECTYS8 citations73
US9657311B2May 23, 2017
Lentiviral vectors containing an MHC class I, MHC class II, or B2 microglobulin upstream promoter sequence
THERAVECTYS5 citations67
US8951535B2Feb 10, 2015
Lentiviral vectors containing an MHC class I promoter
THERAVECTYS1 citations46
US9752160B2Sep 5, 2017
Use of non-subtype B gag proteins for lentiviral packaging
THERAVECTYS0 citations43
US9987351B2Jun 5, 2018
Lentiviral vectors for generating immune responses against human T Lymphotrophic Virus Type 1
THERAVECTYS0 citations39
US10864265B2Dec 15, 2020
Lentiviral vectors for expression of hepatitis B virus (HBV) antigens
THERAVECTYS0 citations36